Roughly 15–25% of all breast cancers are categorized “triple-negative breast cancers” (TNBC), which is a subtype of breast cancer that tests negatively for progesterone, estrogen, and “human epidermal growth factor-2” (HER-2) [2]. Here, ERBB2 is linked to breast cancer.